|
|
|
|
Vol. 54, Issue 5, 755-760, November 1998
1A-Adrenoceptors in Rat-1 Cells
Inhibits Extracellular Signal-Regulated Kinase by Activating p38
Mitogen-Activated Protein Kinase
Departments of
Medicine (A.A., S.K., M.C.M.) and
Urology (M.G.),
University of Essen, 45122 Essen, Germany
In Rat-1 fibroblasts, endothelin-1 and a protein kinase C-stimulating
phorbol ester stimulated extracellular signal-regulated kinase (ERK),
whereas phenylephrine, acting at stably transfected human
1A-adrenoceptors, inhibited basal and endothelin-1- and phorbol ester-stimulated ERK. On the other hand, phenylephrine stimulated p38 mitogen-activated protein kinase (MAPK). Anisomycin caused p38 activation and ERK inhibition quantitatively similar to
those produced by phenylephrine. SB 203,580, an inhibitor of p38,
significantly attenuated phenylephrine- and anisomycin-induced ERK
inhibition. The ERK inhibition by phenylephrine was not affected by the
cytosolic phospholipase A2 inhibitor
arachidonyltrifluoromethyl ketone or the cyclooxygenase inhibitor
indomethacin but was significantly attenuated by a combination of the
phosphatase inhibitors Na3VO4 and okadaic acid.
Neither SB 203,580 nor the phosphatase inhibitors significantly
affected ERK inhibition by the adenylyl cyclase activator forskolin. We
conclude that there is a previously unrecognized interaction between
ERK and p38 MAPK, in which activation of p38 causes inhibition of ERK;
this may at least partly involve MAPK phosphatases that inactivate ERK.
This article has been cited by other articles:
![]() |
B. Xiang, Y. Zhang, Y.M. Li, K. Zhang, Y.Y. Zhang, L.L. Wu, and G.Y. Yu Effects of Phenylephrine on Transplanted Submandibular Gland. J. Dent. Res., December 1, 2006; 85(12): 1106 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Man, S. Rustaeus, D. M. Price, C. L. Chik, and A. K. Ho Inhibition of p38 Mitogen-Activated Protein Kinase Enhances Adrenergic-Stimulated Arylalkylamine N-Acetyltransferase Activity in Rat Pinealocytes Endocrinology, March 1, 2004; 145(3): 1167 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, S. Das, and K. S. Murthy Erk1/2- and p38 MAP kinase-dependent phosphorylation and activation of cPLA2 by m3 and m2 receptors Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G472 - G480. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, S. Belosjorow, P. Gres, J. Jansen, M. C Michel, and G. Heusch p38 MAP kinase is a mediator of ischemic preconditioning in pigs Cardiovasc Res, August 15, 2002; 55(3): 690 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Page, J. Li, and M. B. Hershenson p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L955 - L964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mackova, J. R. Man, C. L. Chik, and A. K. Ho p38MAPK Inhibition Enhances Basal and Norepinephrine-Stimulated p42/44MAPK Phosphorylation in Rat Pinealocytes Endocrinology, November 1, 2000; 141(11): 4202 - 4208. [Abstract] [Full Text] [PDF] |
||||